Home · Open Lab · Lot RGX-25-TESAMORELIN-653
RGX-25-TESAMORELIN-653Superseded
Tesamorelin · 20 MG · Restorative Research · COA NS-2026-05170

Release test results

99.667%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 20.12 mg
Related impurities (total)0.333%
Endotoxin<1.0 EU/mg
HPLC retention time6.79 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundTesamorelin
Presentation20 MG
Lot numberRGX-25-TESAMORELIN-653
COA numberNS-2026-05170
Test date28 Dec 2025
Release date31 Dec 2025
Independent labNordicstar Labs
StatusSuperseded

Tesamorelin — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-TESAMORELIN-104610 MGJul 16, 202699.753%Current
RGX-26-TESAMORELIN-104720 MGJul 15, 202699.584%Current
RGX-26-TESAMORELIN-75410 MGApr 14, 202699.736%Superseded
RGX-26-TESAMORELIN-75320 MGApr 7, 202699.646%Superseded
RGX-26-TESAMORELIN-65410 MGJan 7, 202699.684%Superseded
RGX-25-TESAMORELIN-653 this lot20 MGDec 28, 202599.667%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →